Santen Pharmaceutical Co Ltd at JPMorgan Healthcare Conference Transcript
Good morning, everyone. Welcome to the conference. My name is Naomi Kumagai, Japan pharma analyst at the JPMorgan. It's my great pleasure to introduce Mr. Taniuchi, President and COO of Santen. There's no breakout after the presentation but management is available for one-on-one. With that, over to Taniuchi.
Good morning, everyone. Thank you for joining us. I am Shigeo Taniuchi, President and COO of Santen.
I'm glad to be here. I'll come back again to make a presentation at JPMorgan Healthcare Conference 2020.
Today, in next 20, 25 minutes, I'd like to explain about the Santen and its projects. How we are going to contribute to patients suffering from eye conditions, eye diseases by focusing on innovation in ophthalmology field and explain how we continue our growth.
So first of all, I'd like to start from who we are. Because as a specialty
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
